Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonidine for Neonatal Abstinence Syndrome
NCT00510016Phase 2Completed
- Sponsor
- National Institute on Drug Abuse
- Start
- Jul 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of clonidine in neonatal abstinence syndrome (NAS) (2 arms), sponsored by National Institute on Drug Abuse. Primary endpoint: Length of treatment for neonatal abstinence syndrome. Started Jul 2002; status: completed.
02
Drugs
clonidine
03
Conditions
neonatal abstinence syndrome (NAS)
Beyond the preview
Go deeper on NCT00510016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00510016.